Plexus (NASDAQ:PLXS) Releases Q3 2026 Earnings Guidance

Plexus (NASDAQ:PLXS) updated its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 2.020-2.180 for the period, compared to the consensus earnings per share estimate of 1.930. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.1 billion.

Plexus Trading Up 1.7%

Shares of PLXS stock traded up $4.27 on Wednesday, hitting $250.60. The company had a trading volume of 594,293 shares, compared to its average volume of 349,275. Plexus has a twelve month low of $115.35 and a twelve month high of $259.05. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. The firm has a market cap of $6.71 billion, a P/E ratio of 38.97 and a beta of 0.75. The stock’s 50-day moving average is $209.64 and its two-hundred day moving average is $177.47.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, April 29th. The technology company reported $1.82 EPS for the quarter, missing analysts’ consensus estimates of $1.88 by ($0.06). Plexus had a return on equity of 12.39% and a net margin of 4.28%.Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. On average, equities research analysts anticipate that Plexus will post 6.56 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on PLXS shares. Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research report on Sunday, March 8th. Benchmark reiterated a “buy” rating and set a $220.00 price objective on shares of Plexus in a research report on Monday, March 16th. Weiss Ratings downgraded shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday. Needham & Company LLC boosted their target price on shares of Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a report on Friday, January 30th. Finally, Zacks Research cut shares of Plexus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 13th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Plexus currently has an average rating of “Moderate Buy” and a consensus price target of $204.20.

Insider Transactions at Plexus

In other news, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of Plexus stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $203.06, for a total value of $873,767.18. Following the completion of the sale, the chief accounting officer owned 20,099 shares in the company, valued at $4,081,302.94. The trade was a 17.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Oliver K. Mihm sold 9,541 shares of the business’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total transaction of $1,921,557.40. Following the transaction, the chief operating officer owned 12,809 shares in the company, valued at $2,579,732.60. The trade was a 42.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 50,995 shares of company stock valued at $10,345,971. 1.78% of the stock is owned by insiders.

More Plexus News

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Plexus reported record fiscal Q2 revenue of $1.164B (≈+18.7% YoY) and GAAP operating margin of 5.3%; strong top-line growth is a key upside driver for the stock. Press Release
• Positive Sentiment: Plexus issued Q3 fiscal 2026 guidance of $2.020–$2.180 EPS and revenue $1.2B–$1.3B, above consensus — this upward guidance is likely driving the intraday rally. Q2 Results & Guidance
• Neutral Sentiment: EPS came in at $1.82, up ~29% YoY but missing the consensus (~$1.88/$1.92 in some reports); revenue beat but the EPS shortfall tempers the headline beat. Press Release
• Neutral Sentiment: Analyst coverage remains constructive (recent Buy ratings and a median 6‑month target around $220), but some targets are below current levels—keeps valuation debate active. Quiver Quant
• Negative Sentiment: Plexus disclosed a planned CFO retirement (Patrick Jermain), which introduces short‑term succession risk and could concern investors focused on financial leadership continuity. CFO Transition
• Negative Sentiment: Significant insider selling activity has been reported (multiple senior execs sold shares in recent months), which can weigh on sentiment even though institutional ownership moves are mixed. Insider Activity
• Negative Sentiment: Operational cash from operations declined and total liabilities rose YoY, which are items to monitor for liquidity and capital allocation. Financial Details

Hedge Funds Weigh In On Plexus

Institutional investors have recently made changes to their positions in the stock. Johnson Financial Group Inc. bought a new position in shares of Plexus during the 3rd quarter worth about $72,000. EverSource Wealth Advisors LLC increased its position in Plexus by 583.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after buying an additional 490 shares in the last quarter. Kemnay Advisory Services Inc. acquired a new position in Plexus during the 4th quarter worth approximately $88,000. Smartleaf Asset Management LLC raised its stake in Plexus by 13.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 916 shares of the technology company’s stock worth $137,000 after buying an additional 110 shares during the period. Finally, Corient Private Wealth LLC bought a new position in Plexus in the second quarter worth approximately $210,000. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.